SciELO - Scientific Electronic Library Online

 
vol.29 issue4Systemic sclerosis in a patient with Turner syndrome: A case report and a review of associated autoimmune diseasesGuillain Barré syndrome in the paediatric population. Consequence of active infection or long Covid? author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Revista Colombiana de Reumatología

Print version ISSN 0121-8123

Abstract

ACUNA HERNANDEZ, Marylin; PITALUA CORTES, Quetzali  and  SANCHEZ ORDUZ, Liset. Use of PET/CT as a diagnostic tool in various clinical scenarios related to systemic lupus erythematosus. Rev.Colomb.Reumatol. [online]. 2022, vol.29, n.4, pp.331-334.  Epub Aug 14, 2023. ISSN 0121-8123.  https://doi.org/10.1016/j.rcreu.2021.03.011.

Systemic lupus erythematosus (SLE) is a systemic disease mediated by immune complexes of unknown aetiology that generates excessive production of autoantibodies against components of the cell nucleus, generating multisystemic involvement affecting organs or systems such as the central nervous, cardiovascular, haematolymphoid, musculoskeletal, kidney, serous, skin and subcutaneous tissue cells, among others. 2-Fluoro-2-deoxyglucose (FDG) is a glucose analogue that has been shown to be a useful diagnostic tool to establish the initial systemic involvement of this disease and response to the various treatments used.

Keywords : Lupus erythematosus systemic; Positron emission tomography computed tomography; Diagnostic imaging.

        · abstract in Spanish     · text in English | Spanish     · English ( pdf ) | Spanish ( pdf )